Federal contractor profile

GLAXOSMITHKLINE, LLC

UEI FRHTPHMZMX47CAGE 667E9Company website ↗

Active

Overview

Legal name
GLAXOSMITHKLINE, LLC
Registered location
DURHAM, NC, USA
Website
Company website ↗
Primary NAICS
325412 — Pharmaceutical Preparation Manufacturing
Latest award activity
Sep 1, 2026
Read company summary

GLAXOSMITHKLINE, LLC is associated with UEI FRHTPHMZMX47 and CAGE 667E9 in public federal records. AcornBids currently links 55 prime awards totaling $181.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); Pharmaceutical Preparation Manufacturing; Biological Product (except Diagnostic) Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists DURHAM, NC, USA.

At a glance

Lifetime prime obligations$181.5M
Prime awards55
Awards with future end dates11
Top-agency concentration99.2%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 4, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name
GLAXOSMITHKLINE, LLC
UEI
FRHTPHMZMX47
CAGE
667E9
Registered address
410 BLACKWELL ST, DURHAM, NC, 27701, USA
Registration status
Active
Primary NAICS
325412 — Pharmaceutical Preparation Manufacturing
SAM activation
Jan 14, 2026
Initial registration
Oct 25, 2010
Entity start
Oct 27, 2009
SAM updated
Jan 14, 2026
Registration expires
Jan 12, 2027
Fiscal year end
Dec 31
Place of incorporation
DE, USA

View SAM.gov source

Research brief

Source facts

  • Loaded prime-award records link 55 awards and $181,541,828 in reported obligations to this legal entity. Source
  • Recorded awards include Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714); this classification is not proof of every company capability. Source
  • An example award describes: THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD. Source

Federal award analysis

Net transaction obligations by federal fiscal period.

Selected transaction obligations$104.0M
Prime contracts

Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 55 of 55 selected awards. Select a period to explore its awards.

Funding change

Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.

MeasureReported value
Current periodOct 1, 2025 – Sep 30, 2026
Current obligations$21.5M
Prior periodOct 1, 2024 – Sep 30, 2025
Prior obligations$29.9M
Change$-8.4M
Growth-28.0%

Where the work is performed

AKMEVTNHWAIDMTNDMNWIMINYMAORNVWYSDIAILINOHPANJCTRICAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFL

State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.

Agencies
Offices
Naics
Psc
Vehicles
CategoryPeriod obligationsAwards
75A50122D00002$72.9M18
Unclassified$27.4M4
75D30123D16461$2.1M1
HHSO100201600004I$860.8K5
36F79722D0178$713.0K4
15F06722A0000187$187.3K3
VA797P17C0019$-2.2K1
36E79724D0005$-8.0K14
HHSO100201200013I$-12.7K2
V797P2298D$-118.3K3
States
CategoryPeriod obligationsAwards
NC$99.4M48
PA$4.7M1
NJ$2.3K2
OK$8821
Unclassified$-31
TX$-1.5K1
CA$-21.8K1
Set Asides
CategoryPeriod obligationsAwards
Unclassified$76.5M48
NO SET ASIDE USED.$27.6M7

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / descriptionAwarding agencyObligationsStart dateEnd date
75A50122F61004THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES…Department of Health and Human Services$22.9MSep 14, 2022Jun 30, 2025
75A50126F61021FILL/FINISH ADJUVANT (AS03): MULTI-DOSE VIALSDepartment of Health and Human Services$438.0KSep 1, 2026Aug 31, 2027
75A50325C00019RELENZA (ZANAMIVIR) ROTADISK, 5MGDepartment of Health and Human Services$27.3MSep 30, 2025Sep 29, 2028
75A50122F61001THE PURPOSE OF THIS TASK ORDER IS TO PROCURE SERVICES FOR STORAGE AND STABILITY VACCINE BULK LOTS FROM PRIOR CONTRACTS FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ…Department of Health and Human Services$2.0MFeb 22, 2022Dec 31, 2023
15F06726F0000234GSK VACCINESDepartment of Justice$113.0KFeb 27, 2026Dec 31, 2026
75A50119F33011CLAIMSDepartment of Health and Human Services$976.6KSep 30, 2019Sep 30, 2019
HHSO10033005TASPR-18-00648Department of Health and Human Services$2.0MJan 9, 2018Dec 31, 2018
75A50123F61005PURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT #…Department of Health and Human Services$4.7MDec 12, 2022Feb 21, 2024
75A50124F61013THE PURPOSE OF THIS TASK ORDER IS TO ESTABLISH FILL/FINISH ACTIVITIES FOR ADJUVANT (AS03) TO SUPPORT THE COVID-19 FEDERAL RESPONSE- MULTI-DOSE VIALS FOR HHS UNDER IDIQ CONTRACT…Department of Health and Human Services$15.4MFeb 27, 2024Feb 21, 2027
75A50124F61014THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND…Department of Health and Human Services$18.2MMay 10, 2024Feb 21, 2027

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

GSK VACCINES
Department of Justice$113.0K obligationsEnds Dec 31, 202675% recompete estimate

Registration, certifications & contacts

Registration evidenceDate
SAM updatedJan 14, 2026
Source loadedSep 26, 2026
Initial registrationOct 25, 2010
Entity startOct 27, 2009
IndustryReported size status
325411 — Medicinal and Botanical ManufacturingNot reported
325412 — Pharmaceutical Preparation ManufacturingNot reported
325414 — Biological Product (except Diagnostic) ManufacturingNot reported
ContactRolePublished contact methodsEvidenceSource date
RHONDA BERUBEGovernment businessContact method not publishedSAM registrationNot available
KATHERINE FOLEYAlternate government businessContact method not publishedSAM registrationNot available
RHONDA E BERUBEElectronic businessContact method not publishedSAM registrationNot available
KATHERINE M FOLEYAlternate electronic businessContact method not publishedSAM registrationNot available
Registered industries
  • 325411 — Medicinal and Botanical Manufacturing
  • 325412 — Pharmaceutical Preparation Manufacturing
  • 325414 — Biological Product (except Diagnostic) Manufacturing

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source

Related companies worth researching

Explore the customer, work and award-size evidence behind each match.

SANOFI VACCINES US INC.

3 shared agency customer(s); Shared work: 325412 — Pharmaceutical Preparation Manufacturing, 325414 — Biological Product (except Diagnostic) Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
15 awards

SEQIRUS USA INC

2 shared agency customer(s); Shared work: 325412 — Pharmaceutical Preparation Manufacturing, 325414 — Biological Product (except Diagnostic) Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
15 awards

ADVANCED CELL DIAGNOSTICS, INC.

1 shared agency customer(s); Shared work: 325412 — Pharmaceutical Preparation Manufacturing, 325414 — Biological Product (except Diagnostic) Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
7 awards

QIAGEN, LLC

2 shared agency customer(s); Shared work: 325414 — Biological Product (except Diagnostic) Manufacturing, 541714 — Research and Development in Biotechnology (except Nanobiotechnology). Counts and amounts describe sampled matching awards, not the company’s full history.
6 awards

UNIVERSITY OF WASHINGTON

1 shared agency customer(s); Shared work: 325414 — Biological Product (except Diagnostic) Manufacturing, 541714 — Research and Development in Biotechnology (except Nanobiotechnology); Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards

MEDIMMUNE LLC

1 shared agency customer(s); Shared work: 325414 — Biological Product (except Diagnostic) Manufacturing, 541714 — Research and Development in Biotechnology (except Nanobiotechnology); Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards
Data coverage and methodology

Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.

Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.

Keep your research moving

Save this company, track changes, and evaluate upcoming work against your targets.

Save to my research Find my fit